GeneDx Holdings Corp. Stock Analysis & AI Score
GeneDx Holdings Corp. (WGS) has an ST Score of 39.8 (C), driven by its Valuation (B) and held back by its Profitability (D-). Analysts rate it Buy with a $79.50 price target (-10.1% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Diagnostics & Research |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
GeneDx Holdings Corp. (WGS) has an ST Score of 39.8 (C), driven by its Valuation (B) and held back by its Profitability (D-). Analysts rate it Buy with a $79.50 price target (-10.1% downside).
- Strongest
- ValuationB
- Weakest
- ProfitabilityD-
All factor grades
- ValuationB
- Financial StrengthC+
- GrowthC+
- SentimentC+
- ForecastC
- MomentumC-
- ProfitabilityD-
- Piotroski3/9
Contact
WGS stock: frequently asked questions
What is WGS's ST Score?
GeneDx Holdings Corp. (WGS) has an ST Score of 39.8 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is WGS a buy, hold, or sell?
Analysts rate WGS a Buy, with a price target of $79.50 (-10.1% vs the current price). Our ST Score grades it C (39.8/100). The ST Score is a data-driven signal, not a recommendation.
What are WGS's factor grades?
Valuation B, Profitability D-, Financial Strength C+, Momentum C-, Growth C+, Forecast C, Sentiment C+.
What is WGS's valuation grade?
GeneDx Holdings Corp. (WGS) earns a valuation grade of B, measured against Medical - Diagnostics & Research peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is WGS's growth grade?
GeneDx Holdings Corp. (WGS) earns a growth grade of C+, measured against Medical - Diagnostics & Research peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is WGS's profitability grade?
GeneDx Holdings Corp. (WGS) earns a profitability grade of D-, measured against Medical - Diagnostics & Research peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is WGS's financial strength grade?
GeneDx Holdings Corp. (WGS) earns a financial strength grade of C+, measured against Medical - Diagnostics & Research peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for WGS?
The average analyst price target for GeneDx Holdings Corp. (WGS) is $79.50 from 11 analysts, which is -10.1% versus the recent price of $88.48.
What is WGS's Piotroski score?
GeneDx Holdings Corp. (WGS) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.